Prelude Therapeutics Incorporated Share Price
PRLDPrelude Therapeutics Incorporated Stock Performance
Open $4.57 | Prev. Close $4.43 | Circuit Range N/A |
Day Range $4.22 - $4.64 | Year Range $0.61 - $4.64 | Volume 7,248 |
Average Traded $4.39 |
Prelude Therapeutics Incorporated Share Price Chart
About Prelude Therapeutics Incorporated
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT3789, a selective degrader of SMARCA2 protein for the treatment of advanced or metastatic solid tumors with loss of SMARCA4 due to truncating mutation and/or deletion; PRT7732, a selective and orally bioavailable SMARCA2 degraders to treat advanced or metastatic solid tumors; and PRT2527, a cyclin-dependent kinase 9 inhibitor for the treatment of advanced solid tumors. The company's CDK9 program is a regulator of cancer-promoting transcriptional programs, including MCL1, MYC, and MYB. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.
Prelude Therapeutics Incorporated Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
07-Apr-26 | $3.78 | $4.42 | +19.92% |
06-Apr-26 | $3.65 | $3.69 | +4.83% |
02-Apr-26 | $3.49 | $3.52 | +2.33% |
01-Apr-26 | $3.60 | $3.44 | +1.18% |
31-Mar-26 | $3.29 | $3.40 | +11.11% |
30-Mar-26 | $3.15 | $3.06 | -0.97% |
27-Mar-26 | $3.31 | $3.09 | -4.63% |
FAQs on Prelude Therapeutics Incorporated Share Price
Can I buy Prelude Therapeutics Incorporated shares in India?
What is the share price of Prelude Therapeutics Incorporated?
What is the 5 year returns of Prelude Therapeutics Incorporated?
What are the high & low stock price of Prelude Therapeutics Incorporated today?
What is the 52-week high and low of Prelude Therapeutics Incorporated stock?